We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Multifocal Brain Surgery Reduces Epileptic Seizures

By HospiMedica staff writers
Posted on 05 Jun 2006
A new surgical approach using invasive intracranial monitoring can reduce seizure frequency in children with tuberous sclerosis complex (TSC), according to a new study. More...


In the study, conducted by researchers from New York University Medical Center (NYU, USA), 25 TSC patients with a median age of four years underwent surgical removal of the tubers. In the first stage of the approach developed by the NYU team, electrodes are placed to identify primary and secondary epileptic foci. In the second stage, these foci are resected. With a third stage, electrodes are reimplanted after resection and any residual foci identified are resected.

Twenty-two of the patients underwent a three-stage surgical approach and three had a two-stage approach. Thirteen of the patients had bilateral electrode placement and 12 had unilateral placement. At six months or longer following surgery, 21 of the children were seizure-free or had only non-disabling simple partial seizures. The remaining children included two who experienced a higher-than-90% drop in seizure frequency and two with a lower-than-50% reduction in frequency. Four of five children who were not originally considered candidates for surgery, due to multiple seizure foci, were rendered seizure-free with the multi-stage approach. The results were reported in the May 2006 issue of Pediatrics.

"This approach can help to identify both primary and secondary epileptogenic zones in young TSC patients with multiple tubers, and may be suitable for some patients with multiple seizure foci,” conclude lead author Dr. Howard L. Weiner and colleagues. "Long-term follow-up will determine whether this approach has durable effects.”

The seizures seen with TSC are usually due to cortical tubers and do not respond to medical therapy. Surgical removal of the tubers, along with the surrounding epileptogenic zone, has shown some promise in reducing seizure frequency, but it is often difficult to define the margins of the zone.



Related Links:
New York University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.